Display Settings:

Format

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
    Int J Med Sci. 2012;9(5):339-52. doi: 10.7150/ijms.4414. Epub 2012 Jul 1.

    BioShuttle mobility in living cells studied with high-resolution FCS & CLSM methodologies.

    Source

    Dept. of Imaging and Radiooncology, German Cancer Research Center, Im Neuenheimer Feld 280, Heidelberg, Germany. k.braun@dkfz.de

    Abstract

    With the increase in molecular diagnostics and patient-specific therapeutic approaches, the delivery and targeting of imaging molecules and pharmacologically active agents gain increasing importance. The ideal delivery system does not exist yet. The realization of two features is indispensable: first, a locally high concentration of target-specific diagnostic and therapeutic molecules; second, the broad development of effective and safe carrier systems. Here we characterize the transport properties of the peptide-based BioShuttle transporter using FFM and CLSM methods. The modular design of BioShuttle-based formulations results in a multi-faceted field of applications, also as a theranostic tool.

    PMID:
    22811608
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC3399214
    Free PMC Article

    Images from this publication.See all images (9)Free text

    Figure 1
    Figure 3
    Figure 5
    Figure 7
    Figure 9
    Figure 2
    Figure 4
    Figure 6
    Figure 8

      Supplemental Content

      Icon for Ivyspring International Publisher Icon for PubMed Central

      Save items

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk